Cytosurge AG provides precision cell engineering and single-cell manipulation solutions based on its proprietary FluidFM® technology. Its CellEDIT service generates custom CRISPR-engineered mammalian cell lines using direct, vector-free intra-nuclear delivery of editing reagents, providing precise control while minimizing the cellular impact associated with conventional transfection methods.
CellEDIT supports applications including knockouts, knock-ins, point mutations, and multiplex gene editing, including work with hard-to-transfect cell lines. Cytosurge also develops FluidFM systems and probes for single-cell injection, extraction, profiling, and manipulation, supporting research across gene engineering, drug discovery, cell biology, neuroscience, and other life science applications.
Key Features and Capabilities:
- Vector-free Single-Cell Transfection: CellEDIT utilizes precise and targeted direct intra-nuclear injections of single cells to deliver editing reagents. This capability is invaluable for introducing specific gene edits into cells with utmost accuracy.
- High Precision and Control: The CellEDIT service offers exceptional accuracy and control in single-cell transfection. With its unique microfluidic force probing cantilever technology, we can precisely control the injected volume of CRISPR Cas9 RNP into the nucleus, reducing off-targeting effect.
- Versatility and Compatibility: CellEDIT is compatible with mammalian cells. Researchers can tailor the service to their specific research needs, enabling a wide range of applications across multiple scientific disciplines, including cell biology, immunology, neuroscience, regenerative medicine, and drug discovery.
- Expert Support: The CellEDIT service offered through Scientist.com is backed by a team of experienced scientists and technical experts. They provide guidance and support throughout the project, ensuring researchers and scientists to achieve optimal results and maximize the potential of the CellEDIT Service
